Breaking News
Get 55% Off 0
Final hours! Save up to 55% OFF InvestingPro
CLAIM SALE
Close

Ubs (lux) Investment Sicav - China A Opportunity (usd) I-a2-acc Usd (0P0001EGG6)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
92.730 +0.060    +0.06%
20/12 - Delayed Data. Currency in USD
  • Morningstar Rating:
  • Total Assets: 1.18B
Type:  Fund
Market:  Luxembourg
Issuer:  UBS Fund Management (Luxembourg) S.A.
ISIN:  LU1675058645 
Asset Class:  Equity
UBS (Lux) Investment SICAV - China A Opportunity ( 92.730 +0.060 +0.06%

0P0001EGG6 Holdings

 
Comprehensive information about top holdings and Key Holding Information for the UBS (Lux) Investment SICAV - China A Opportunity ( (0P0001EGG6) fund. Our UBS (Lux) Investment SICAV - China A Opportunity ( portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 10.300 12.110 1.810
Stocks 89.700 89.700 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 14.832 14.676
Price to Book 2.353 2.100
Price to Sales 2.876 1.746
Price to Cash Flow 15.489 9.308
Dividend Yield 3.137 2.652
5 Years Earnings Growth 7.425 10.903

Sector Allocation

Name  Net % Category Average
Consumer Defensive 25.990 13.448
Healthcare 24.580 8.613
Consumer Cyclical 16.250 11.194
Financial Services 15.900 21.238
Communication Services 13.760 3.152
Basic Materials 1.940 8.040
Real Estate 1.130 2.656
Industrials 0.450 19.187

Region Allocation

  • Asia
  • Emerging Markets
  • Developed Markets

Top Holdings

Number of long holdings: 46

Number of short holdings: 8

Name ISIN Weight % Last Change %
  Kweichow Moutai CNE0000018R8 11.06 1,526.45 +0.29%
  China Merchants Bank CNE000001B33 9.55 38.35 +1.16%
  Yunnan Baiyao A CNE0000008X7 8.71 60.53 +0.93%
  Fuyao Glass A CNE000000230 5.81 59.81 +0.50%
  Tencent Holdings KYG875721634 4.67 420.20 -1.45%
  Dong-E E-Jiao A CNE0000006Y9 3.96 62.94 -0.41%
  Inner Mongolia Yili CNE000000JP5 3.88 29.60 +1.37%
  Jiangsu Hengrui CNE0000014W7 3.63 45.85 -0.86%
  Midea Group A CNE100001QQ5 3.48 74.61 +0.82%
  NetEase KYG6427A1022 3.39 144.20 +0.91%

Top Equity Funds by UBS Asset Management (Europe) S.A.

  Name Rating Total Assets YTD% 3Y% 10Y%
  LU1313519925 6.65B 0.61 0.70 -
  LU1300848345 6.65B 0.85 1.00 -
  LU1520716801 4.04B 5.79 2.11 -
  LU1323611266 4.04B 3.95 -0.16 -
  UBS Lux Equity Fund China Opportuni 2.85B 9.57 -10.68 4.90
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0001EGG6 Comments

Write your thoughts about Ubs (lux) Investment Sicav - China A Opportunity (usd) I-a2-acc Usd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email